Biotech Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update August 13, 2024
Biotech PeproMene Bio announced study demonstrating strong polyfunctionality of novel chimeric antigen receptor (CAR) T cells August 12, 2024
Biotech Onassis Holdings Retained Investment Bank Dalmore Group to Launch up to $75 Million Regulation A+ Offering (Mini IPO) July 22, 2024
Biotech Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024 July 22, 2024
Biotech Astellas and Graduate School of Medicine / Faculty of Medicine, Osaka University Enter into Research Collaboration to Develop Pluripotent Stem Cell-Derived Cartilage Organoid Cell Therapy July 22, 2024
Biotech Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors July 22, 2024
Biotech Biosion Today Presented Key Phase 2 POC Clinical Study Results for Bosakitug, an Anti-TSLP mAb, in Atopic Dermatitis Subjects at the Revolutionizing Atopic Dermatitis Conference June 18, 2024